Depo-Provera Litigation After the Settlement: What Attorneys Need From OB/GYN and Epidemiology Experts

The Depo-Provera settlement leaves an estimated one in five federal claims outside the program, and the fights that remain turn on duration of use, timing of diagnosis, latency and label history. Here is what the court’s own orders require, what the epidemiology shows, and why OB/GYN and epidemiology experts now sit at the center of MDL 3140.

Read More...